Chemotherapy with THP-containing Regimen for the Treatment of Advanced Breast Cancer
Abstract：Objective:To evaluate efficacy and toxicity of THP-containing regimen in the treatment of advanced breast Cancer.Methods:36 cases of advanced breast cancer patients based on their own conditions,respectively,the application of THP based combination chemotherapy in CTF or CTP intervention, 1 years after curative effect and adverse reaction evaluation.Results:All patients underwent telephone follow-up of 1 years,the follow-up rate was 100.00%,in 36 patients,34 cases survived,the survival rate was 94.44%,with an efficiency of 41.18%.Survival in patients with average remission 5.7 months respectively, the median survival time was 9.9 months.In all patients after three months earlier after the completion of chemotherapy,gastrointestinal side effects were the most, followed by varying degrees of fever,abdominal pain and diarrhea are obvious.Conclusion:THP containing regimen is an active regimen for patients with advanced breast cancer with low toxicity and worthy of being widely used in the clinical.
Keywords：Breast cancerPirarubicin
Publication Date：2013-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)